Company intelligence / Profile preview

Briotech

Woodinville, Washington, United Statesbriotechusa.shop ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Briotech produces pure, stable Hypochlorous Acid (HOCl) solutions that have been tested by the National Institutes of Health. Their BrioHOCl formula successfully inactivated prions in a federally funded study, which are responsible for diseases like mad-cow disease and Creutzfeldt-Jakob Disease (CJD)[5].

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Hypochlorous Acid (HOCl) solutions
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Briotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Briotech.

Explore the full profile